Review
Open access
Sep 2026
Towards personalized treatment in juvenile idiopathic arthritis: moving beyond the trial-and-error strategy.
The progressive elucidation of juvenile idiopathic arthritis (JIA) pathogenesis has led to growing interest in biomarkers to support diagnosis, subset classification, detection of subclinical inflammation, and/or prediction of disease course and therapeutic response (theragnostic biomarkers). JIA management in clinical...
A. Marino, Marco Pandolfi, M. G. Lommano et al.
· Current Opinion in Immunolog... · 0 citations